168 related articles for article (PubMed ID: 34586695)
1. Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.
Galassi G; Marchioni A
Eur J Neurol; 2022 Jan; 29(1):e5-e6. PubMed ID: 34586695
[No Abstract] [Full Text] [Related]
2. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubikova M; Tyblova M; Tesar A; Magda H; Daniela V; Irena R; Iveta N; Kristyna D; Pavel D; Jiri P; Stanislav V; Josef B
Eur J Neurol; 2022 Jan; 29(1):e7-e8. PubMed ID: 34699086
[No Abstract] [Full Text] [Related]
3. Comment on COVID-19 in patients with myasthenia gravis.
Galassi G; Marchioni A
Muscle Nerve; 2020 Dec; 62(6):E85-E86. PubMed ID: 32929765
[No Abstract] [Full Text] [Related]
4. Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".
Nóbrega PR; Junior PHO; de Freitas HC; D'almeida JAC; Rodrigues CL
Neurol Sci; 2022 Oct; 43(10):5805-5806. PubMed ID: 35941335
[No Abstract] [Full Text] [Related]
5. Reply to Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".
Galassi G; Marchioni A
Neurol Sci; 2022 Dec; 43(12):6665-6666. PubMed ID: 36071266
[No Abstract] [Full Text] [Related]
6. The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis.
Galassi G
Neurol Sci; 2022 Oct; 43(10):5803-5804. PubMed ID: 35759066
[No Abstract] [Full Text] [Related]
7. Myasthenic crisis in COVID-19.
Delly F; Syed MJ; Lisak RP; Zutshi D
J Neurol Sci; 2020 Jul; 414():116888. PubMed ID: 32413767
[TBL] [Abstract][Full Text] [Related]
8. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19.
Hofstadt-van Oy U; Stankovic S; Kelbel C; Oswald D; Larrosa-Lombardi S; Barchfeld T; Cleff U
J Neurol; 2021 Sep; 268(9):3125-3128. PubMed ID: 33537898
[TBL] [Abstract][Full Text] [Related]
9. Does the virus or the doctor promote myasthenic crises in COVID-19 patients with myasthenia?
Finsterer J; Ghosh R
J Clin Anesth; 2021 Jun; 70():110166. PubMed ID: 33472763
[No Abstract] [Full Text] [Related]
10. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review.
Tereshko Y; Gigli GL; Pez S; De Pellegrin A; Valente M
J Neurol; 2023 Feb; 270(2):601-609. PubMed ID: 36352330
[TBL] [Abstract][Full Text] [Related]
11. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy.
Chu XY; Xue ZQ; Wang RW; Tan QY
Chin Med J (Engl); 2011 Apr; 124(8):1246-50. PubMed ID: 21543005
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
Galassi G; Marchioni A
Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubíková M; Týblová M; Tesař A; Horáková M; Vlažná D; Ryšánková I; Nováková I; Dolečková K; Dušek P; Piťha J; Voháňka S; Bednařík J
Eur J Neurol; 2021 Oct; 28(10):3418-3425. PubMed ID: 34080271
[TBL] [Abstract][Full Text] [Related]
14. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis.
Leuzzi G; Meacci E; Cusumano G; Cesario A; Chiappetta M; Dall'armi V; Evoli A; Costa R; Lococo F; Primieri P; Margaritora S; Granone P
Eur J Cardiothorac Surg; 2014 Apr; 45(4):e76-88; discussion e88. PubMed ID: 24525106
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in Patients with Myasthenia Gravis: Mechanisms of Respiratory Failure.
Murthy JMK; Gutta AK; Yerasu MR; Boorgu SK; Osman S; Jaiswal SK; Pidaparthi L; Gudavalli BP
Neurol India; 2021; 69(6):1772-1776. PubMed ID: 34979686
[TBL] [Abstract][Full Text] [Related]
17. Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.
Wanschitz JV; Kaml M; Pfausler B; Helbok R; Wildner S; Widmann G; Sahanic S; Deisenhammer F; Löscher WN; Reindl M; Löffler-Ragg J; Beer R
J Neurol; 2021 Aug; 268(8):2700-2702. PubMed ID: 33216224
[No Abstract] [Full Text] [Related]
18. Clinical course and outcome of Covid-19 in patients with myasthenia gravis.
Aktoz G; Boz C; Zengin S; Okumus AC; Horozoglu H; Kara F; Oral E; Ozmenoglu M
Neurol Res; 2023 Jun; 45(6):583-589. PubMed ID: 36681934
[TBL] [Abstract][Full Text] [Related]
19. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
[TBL] [Abstract][Full Text] [Related]
20. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
Hoang P; Hurtubise B; Muppidi S
Neurology; 2020 Nov; 95(18):840-843. PubMed ID: 32817186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
